Pseudoprogression in patients with glioblastoma: clinical relevance despite low incidence

BACKGROUND: According to the Response Assessment in Neuro-Oncology criteria, new enhancement within the radiation field on contrast enhanced T1-weighted images within 12 weeks after completion of radiotherapy should not qualify for progressive disease, since up to 50% of these cases may be pseudopro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Radbruch, Alexander, Fladt, Joachim, Kickingereder, Philipp, Wiestler, Benedikt, Nowosielski, Martha, Bäumer, Philipp, Schlemmer, Heinz-Peter, Wick, Antje, Heiland, Sabine, Wick, Wolfgang, Bendszus, Martin
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
Imaging
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4483046/
https://ncbi.nlm.nih.gov/pubmed/25038253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou129
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados